Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Amanat Acquisition Corp.

NASDAQ: AMAN · Real Estate & Construction · 1 alert · CIK 2112457

Share price
$10.10Close, Nov 16
Sector
Real Estate & Construction
Industry
Blank ChecksSIC 6770

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Amanat Acquisition Corp. filings on SEC EDGAR ↗

6:13 AM ET 8-K
M&A Deal

Amanat Acquisition Signs $377M M&A Deal with Corxel Pharmaceuticals, Inc.

Amanat Acquisition Corp (AMAN) has entered into a definitive business combination agreement with Corxel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on oral obesity therapies. The transaction is expected to provide approximately $377 million in gross proceeds, including a $300 million PIPE investment from institutional investors. Upon closing, expected in the first half of 2027, the combined company will focus on advancing Corxel's oral GLP-1 receptor agonist, CX11, into Phase 3 clinical trials.

Value
$377M
Counterparty
Corxel Pharmaceuticals, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.